A landmark report released by Volteface has highlighted the need to engage with UK clinicians on issues around evidence and governance if we are to see wider prescribing amongst sp
Newly released Hodges Review supports recommendations to roll out a national trial for GP prescribing of CBPMs based on an opt-in model for doctors’ consent and systematic
The Congress. of Deputies in Spain has given the green light to regulating medical cannabis for therapeutic purposes and the new treatment should be available from hospital and com
The FSA has issued a provisional list of CBD products on sale in England and Wales that can remain on the market because an application for safety assessment has been submitted to
Medical cannabis has been legal to prescribe since 2018—yet just a handful of prescriptions have been made in three years. The reasons: stigma, fear, and an entrenched resistance
Dr David Bailey has been a GP on Jersey since 1996, he has interests in substance misuse and vulnerable adults. For fun he swims in the sea and takes photographs. He co-founded Sus
We are a few months into the operation of our PGP medical cannabis clinic. Having been the first multidisciplinary team within the UK to set up such a clinic in the background of a
My name is Mark, I’m a 58 year old UK GP who left for Australia in 2015 with my GP wife after finding running our own separate practices less than rewarding. Here’s my experien
Despite the re-scheduling of cannabis-based medicines almost 2-years ago in the UK, patient access to medical cannabis remains extremely limited with only a few hundred scripts iss